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Diagnostic imaging modalities of osteoblastic metastases 
Osteoblastic metastases are characterized by the neoformation of bone around tumor 
cell deposits. These cells secrete morphogens and growth factors (BMPs, IGF, 
TGFβ,…) that stimulate osteoblasts  to produce collagen, osteocalcin and alkaline 
phosphatases1. The newly formed bone is deposited on trabecular bone, making it more 
dense. These tumoral cells metastasize to the most vascularized parts of the skeleton, 
particularly the red bone marrow of the axial skeleton and the proximal ends of the long 
bones. 
In 80% of the cases, the primary tumor originates in the breast or prostate2. Bone pain is 
the most common clinical consequence and could be the initial presenting symptom. 
Imaging plays a major role given that early identification of skeletal metastases could 
lead to changes in patient management. Clinical evaluation demands multimodal 
diagnostic imaging owing to the limitations of the diagnostic techniques. Four main 
modalities are currently utilized: radiograph, computed tomography, scintigraphy and 
magnetic resonance imaging3-4.  At present, positron emission tomography and single-
photon emission computed tomography have a potential for evaluation5. These 
techniques differ in performance in terms of sensitivity and specificity, but none of the 
modalities alone seem to be able to yield a reliable diagnostic outcome. There is 
currently no agreement on which is the best modality for diagnosing the lesion and for 
assessing its response to treatment. In clinical practice, most oncologists do not even use 
the same criteria, which results in disparate assessments of bone metastases5. 
Radiograph and scintigraphy are the most common imaging modalities used for 
detection.  
Computerized tomography (using the bone window setting) offers better skeletal detail 
than radiographs because of its ability to visualize in sufficient anatomic detail. 
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Scintigraphy remains the technique of choice in asymptomatic patients in whom skeletal 
metastases are suspected. This technique visualizes increases in osteoblastic activity as 
hot spots. However, the technique, albeit very sensitive, is poorly specific, and thus a 
negative bone scan finding is double-checked with an additional examination.  
Magnetic resonance imaging is the only technique that enables us to differentiate 
between bone marrow components. The major limitation of magnetic resonance 
imaging is the poor specificity of its findings, which could result in erroneous findings. 
The capability of magnetic resonance imaging to obtain sagittal views allows large 
sections of the skeleton to be assessed in one imaging session.  
Computerized tomography and magnetic resonance imaging are used less frequently 
than radiographs because of the cost, the restricted availability and the scant data 
available on the sensitivity and specificity of these methods 4-5.  
 
New methods on digitized radiographs   
On radiographs these metastases appear as spots that are whiter than the surrounding 
healthy bone and are sometimes difficult to differentiate from it. This technique is 
commonly used to evaluate symptomatic sites and is a useful complement to 
scintigraphy for clarifying nonspecific or atypical findings or for following up cases in 
which clinical findings indicate bone pain but where scintigraphy findings are negative. 
This is not generally recommended as a screening method because of its poor 
sensitivity. Sensitivity depends partly on location. For instance, metastases to dense 
cortical bone are easier to detect than those involving trabecular bone. The advantages 
of this technique include its wide diffusion, low cost and improved patient comfort.  
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The digitized radiograph image is obtained by scanning the image of a radiograph film, 
which converts an analogue image into a digital one. This modality offers the possibility 
of studying anatomical locations from qualitative and quantitative points of view. 
Radiological diagnosis produces false-negative findings may be due to a misperception 
of osteoblastic metastases. The major cause is a bone marrow sclerosis below the 
threshold for detection on radiograph. False- positive, on the other hand, are an incorrect 
analysis of radiological findings such as trauma, inflammation or healing5. 
The accurate detection of osteoblastic metastases should improve by quantifying these 
lesions, thereby paving the way for computerized methods that would enable us to: 
standardize studies to draw general conclusions, calculate the ideal parameters, define 
patterns of normality and determine the pathology by evaluating deviations of these 
indexes. 
Earlier works, using digitized radiographs, have reported a method designed to improve 
the differential diagnosis between healthy bone and osteoblastic metastases, the primary 
tumors of which was prostate and breast6-7. The material used was 144 radiographs of 
healthy bone and 35 of osteoblastic metastases of 179 subjects. The method is 
summarized on the algorithm as follows: (1) image acquisition, (2) selection of a region 
of interest, (3) filtering, (4) histogram, (5) characterization by parameters, (6) results 
analysis and, (7) discriminatory capacity of the parameters. 
The results showed a good discriminatory ability of the parameters to distinguish 
between healthy trabecular / flat bones and osteoblastic metastases (area under the 
receiver operating characteristic (ROC) of 0.97 and 0.85, respectively)7. 
This method can be helpful as a complementary method for a differential diagnosis and 
has the following advantages: 1) it accurately quantifies the selected regions of healthy 
and osteoblastic metastases, 2) it reduces subjectivity in the interpretation of the image, 
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3) it improves the information contained in the radiograph, 4) it implements in a 
personal computer, 5) it is automatic, 6) it obtains the results on the screen in a shorter 
time and 7) it diminishes the radiation of the patient since a second diagnosis is 
unnecessary in many cases.  
 
Conclusion 
The aim of developing methods that quantify radiograph images is to improve the 
identification of these metastases given that the parameters accurately identify the 
tumoral areas. Consequently, new methods open up new horizons in early diagnosis and 
follow up. Moreover, they can be useful to study the evolution of these metastases 
under treatment. 
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